Boundary Waters Care Center | |
200 West Conan Street, Ely, Minnesota 55731 | |
(218) 365-8705 | |
Name | Boundary Waters Care Center |
---|---|
Location | 200 West Conan Street, Ely, Minnesota |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 42 |
Occupancy Rate | 67.62% |
Medicare ID (CCN) | 245138 |
Legal Business Name | Boundary Waters Care Center |
Ownership Type | Non Profit - Corporation |
NPI Number | 1477660777 |
Organization Name | BOUNDARY WATERS CARE CENTER |
Address | 200 W Conan St, Ely, MN 55731 |
Phone Number | 218-365-8044 |
News Archive
Karen Nolan, PhD, of Kessler Foundation, received a grant from MedRhythms to test the company's investigational digital therapeutic device, the Stride Plus, in individuals striving to recover mobility after stroke.
"More than 40 percent of employers surveyed by the consulting firm Mercer expect health care reform to raise health care costs by a modest 2 percent or less next year," the Associated Press reports.
Investigators at St. Jude Children's Research Hospital have developed a strategy to speed future development of more effective and less toxic treatments for medulloblastoma, a type of brain cancer. Medulloblastomas arise in the back of the brain and account for about 20 percent of childhood brain tumors.
When it comes to risk disclosures made by drug companies in print and television ads, many consumers are not paying attention, according to a recent study by ORC Guideline (an infoGROUP company). The latest study in the company's Under the Skin series found that 41% of US consumers pay little or no attention to risk information presented by pharmaceutical companies in their TV commercials, and only half (50%) pay attention to such disclosures in print ads. This lack of attention is most prevalent among those 55 years of age or older.
Syngene, a world-leading manufacturer of image analysis solutions, is pleased to introduce its UV-Blue Light Converters Screens which can quickly and simply change harmful UV into blue light.
› Verified 6 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
Karen Nolan, PhD, of Kessler Foundation, received a grant from MedRhythms to test the company's investigational digital therapeutic device, the Stride Plus, in individuals striving to recover mobility after stroke.
"More than 40 percent of employers surveyed by the consulting firm Mercer expect health care reform to raise health care costs by a modest 2 percent or less next year," the Associated Press reports.
Investigators at St. Jude Children's Research Hospital have developed a strategy to speed future development of more effective and less toxic treatments for medulloblastoma, a type of brain cancer. Medulloblastomas arise in the back of the brain and account for about 20 percent of childhood brain tumors.
When it comes to risk disclosures made by drug companies in print and television ads, many consumers are not paying attention, according to a recent study by ORC Guideline (an infoGROUP company). The latest study in the company's Under the Skin series found that 41% of US consumers pay little or no attention to risk information presented by pharmaceutical companies in their TV commercials, and only half (50%) pay attention to such disclosures in print ads. This lack of attention is most prevalent among those 55 years of age or older.
Syngene, a world-leading manufacturer of image analysis solutions, is pleased to introduce its UV-Blue Light Converters Screens which can quickly and simply change harmful UV into blue light.
› Verified 6 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 2 |
Total Amount of Fines in Dollars | $17046 |
Number of Payment Denials | 0 |
Total Number of Penalties | 2 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 14.44 | 14.46 |
Percentage of long-stay residents who lose too much weight | 10.64 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 50.98 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.3 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 0.88 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 8.18 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 0 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 98.23 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 21.7 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 93.94 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 1.22 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 44.2 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 15.96 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 10.47 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 96.88 | 95.98 |
Percentage of short-stay residents who made improvements in function | 76.47 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 82.78 | 82.93 |
News Archive
Karen Nolan, PhD, of Kessler Foundation, received a grant from MedRhythms to test the company's investigational digital therapeutic device, the Stride Plus, in individuals striving to recover mobility after stroke.
"More than 40 percent of employers surveyed by the consulting firm Mercer expect health care reform to raise health care costs by a modest 2 percent or less next year," the Associated Press reports.
Investigators at St. Jude Children's Research Hospital have developed a strategy to speed future development of more effective and less toxic treatments for medulloblastoma, a type of brain cancer. Medulloblastomas arise in the back of the brain and account for about 20 percent of childhood brain tumors.
When it comes to risk disclosures made by drug companies in print and television ads, many consumers are not paying attention, according to a recent study by ORC Guideline (an infoGROUP company). The latest study in the company's Under the Skin series found that 41% of US consumers pay little or no attention to risk information presented by pharmaceutical companies in their TV commercials, and only half (50%) pay attention to such disclosures in print ads. This lack of attention is most prevalent among those 55 years of age or older.
Syngene, a world-leading manufacturer of image analysis solutions, is pleased to introduce its UV-Blue Light Converters Screens which can quickly and simply change harmful UV into blue light.
› Verified 6 days ago
Boundary Waters Care Center Location: 200 West Conan Street, Ely, Minnesota 55731 Phone: (218) 365-8705 |